| Literature DB >> 19197376 |
Sean P Dineen1, Christina L Roland, Roderich E Schwarz.
Abstract
Pyloric preservation (PP) can frequently be performed at the time of pancreatoduodenectomy (PD), although some reports have linked it to inferior outcomes such as delayed gastric emptying (DGE). We reviewed records in a single-surgeon practice to assess outcomes after PD with or without PP. There were 133 PDs with 67 PPPDs and 66 PDs. Differences between PPPD and PD groups included cancer frequency, tumor size, OR time, blood loss, and transfusion rate. However, postoperative morbidity rate and grade, NG tube duration, NGT reinsertion rate, DGE, and length of stay were similar. There was no difference among patients with pancreatic cancer. No detrimental outcomes are associated with pyloric preservation during PD. Greater intraoperative ease and superior survival in the PPPD group are due to confounding, tumor-related variables in this nonrandomized comparison. Nevertheless, we intend to continue the use of PP with our technique in patients who meet the stated criteria.Entities:
Year: 2009 PMID: 19197376 PMCID: PMC2633452 DOI: 10.1155/2008/719459
Source DB: PubMed Journal: HPB Surg ISSN: 0894-8569
Figure 1Preservation of the right gastric vasculature and pyloric vagal innervation.
Figure 2Antecolic duodenojejunostomy, hand-sutured dual-layer technique.
Demographic and pathologic data.
| Demographic | Total cohort | PPPD | PD |
| |
|---|---|---|---|---|---|
| Patients ( | 133 | 67 | 66 | N/A | |
| Gender (%) | Female | 59 | 66 | 52 | NS |
| Male | 41 | 34 | 48 | ||
| Age, median (range) (years) | 66 (39–88) | 66 (45–88) | 66 (39–86) | NS | |
| ASA group 3 or greater (%) | 59 | 59 | 60 | NS | |
| Diagnostic group (%) | Malignant | 83 | 76 | 89 | .04 |
| Benign | 17 | 24 | 11 | ||
| Cancer type (% of patients with cancer) | Pancreatic | 64 | 56 | 72 | NS |
| Ampullary | 17 | 25 | 11 | ||
| Other | 18 | 19 | 17 | ||
| Tumor size, mean (cm) | 3.1 | 3.8 | 3.5 | .01 | |
| T3+ (%) | 74 | 73 | 75 | NS | |
| N pos. (%) | 62 | 55 | 68 | NS | |
| Grade 3+ | 82 | 84 | 78 | NS | |
| Total LN count, mean ( | 14.3 | 13.4 | 15.3 | NS | |
| R0 rate (%) | 77 | 83 | 71 | NS |
Operative treatment characteristics.
| Total cohort ( | PPPD ( | PD ( |
| |
|---|---|---|---|---|
| OR time (hour) | 6.4 | 5.8 | 7 | <.0001 |
| EBL (mL) | 527 | 413 | 636 | .006 |
| IVF (mL) | 7381 | 6768 | 7954 | .02 |
| Transfusion rate (%) | 23 | 13 | 33 | .007 |
| Units PRBC, mean | 0.56 | 0.45 | 0.76 | NS |
| Units PRBC per transfused patient ( | 2.2 | 2.2 | 2.2 | NS |
| Urine output per hour operating time, mean (mL) | 141 | 173 | 118 | NS |
Postoperative outcomes.
| Total cohort ( | PPPD ( | PD ( |
| |
|---|---|---|---|---|
| Morbidity (%) | 39 | 39 | 40 | NS |
| Grade 3+ morbidity (%) | 14 | 13 | 14 | NS |
| Pancreatic leak (%) | 11 | 12 | 11 | NS |
| Lethal events ( | 6 | 2 | 4 | NS |
| Median NGT duration (days) | 1 | 1 | 2 | NS |
| NGT reinsertion (%) | 19 | 21 | 17 | NS |
| Delayed gastric emptying (%) | 3.8 | 3.0 | 4.5 | NS |
| Delayed gastric emptying, international study group definition (%) | 6.0 | 6.0 | 6.1 | NS |
| Length of stay, median (d) | 10 | 10 | 10 | NS |
Figure 3Length of hospital stay, by resection group.
Figure 4Overall actuarial survival, by resection group.